OR WAIT null SECS
November 02, 2023
The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.
Industry investments indicate increasing trust in the newest modalities, including mRNA approaches.
October 24, 2023
The final guidance document was issued to assist bio/pharma companies in the clinical development and licensure of COVID-19 vaccines.
October 12, 2023
The companies will co-promote GSK’s shingles vaccine, Shingrix, to healthcare professionals and points of vaccination in China.
October 04, 2023
Pfizer has entered into a collaboration with Ginkgo Bioworks to discover novel RNA molecules across priority research areas.
September 02, 2023
European vaccine manufacturing is being boosted with high level investments.
August 17, 2023
An mRNA conversation about the recent past, current hot topics, and probable future.
Experts discuss the promise of personalized cancer vaccines through the inherent nimbleness of mRNA platform.
August 03, 2023
A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.
July 18, 2023
Jeff Fischer, co-founder and president of Longhorn Vaccines and Diagnostics, discusses the history and ongoing development of both protein- and mRNA-based vaccines.